[1
]
From the Department of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology,
King's College London and Guy's and St. Thomas' National Health Service Foundation
Trust, London (G.D.T., S.R., A.F.S., H.A.B., M.B., M.F., V.T., G.L.), and the University
of Southampton and National Institute for Health Research Respiratory Biomedical Research
Unit, Southampton and David Hide Centre, Newport, Isle of Wight (G.R.) - both in the
United Kingdom; the Division of Hematology-Oncology, Department of Medicine (P.H.S.),
and the Immune Tolerance Network (D.P.), University of California, San Francisco,
San Francisco; Rho Federal Systems Division, Chapel Hill, NC (H.T.B., M.L.S.); and
the National Institute of Allergy and Infectious Diseases, Bethesda, MD (M.G.L., M.P.).